Cargando…
Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)
Autores principales: | Reiger, J, Tatzber, F, Ziervogel, G, Köller, U, Grimm, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301248/ http://dx.doi.org/10.1186/cc136 |
Ejemplares similares
-
Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
por: Stiletto, RJ, et al.
Publicado: (1998) -
Procalcitonin (PCT)
por: Horns, Heidi, et al.
Publicado: (2021) -
Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999) -
A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000) -
Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis
por: LIU, Yu, et al.
Publicado: (2017)